(April 11, 2023, 9:57 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration has announced a final decision to withdraw its approval of the premature birth prevention drug Makena and its generic versions because the drug’s benefits no longer outweigh its risks....